From Framingham to PREVENT: The New Era of Cardiometabolic Risk

The Evolution of How We Measure Heart and Metabolic Disease Risk

For more than half a century, clinicians have relied on population-based equations to estimate who is most likely to develop heart disease, stroke, or diabetes. These tools shaped preventive care — but they were designed for groups, not individuals. Medicine is now shifting toward a personalized approach to prevention. By integrating both cardiovascular and metabolic data, the field of cardiometabolic prevention connects risk factors that were once considered separately.